Philip J. DiSaia Prestigious Chair in Gynecologic Oncology Director, Gynecologic Oncology
Obstetrics & Gynecology
Dr. Robert E. Bristow, MD
|
|
Give Review
Robert Bristow works in the field of Obstetrics & Gynecology. He researched medicine at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31 in research and 72 in primary care medicine He over the years received 8 awards: "America's Top Doctors", "Top Doctors:LA Area", "Top Doctors:San Diego Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "Super Doctor", "Fellow (FACOG)" and "Fellow (FACS)". Robert E. Bristow is a published MD as well. He has 100 publications published. The latest was: Cost Effectiveness Analysis of a Multivariate Index Assay compared to Modified ACOG Criteria and CA-125 in the Triage of Women with Adnexal Masses. He accepts Medicare.
Publications
- Cost Effectiveness Analysis of a Multivariate Index Assay compared to Modified ACOG Criteria and CA-125 in the Triage of Women with Adnexal Masses.
- Sociodemographic disparities in advanced ovarian Cancer survival and adherence to treatment guidelines.
- A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature.
- Spatial analysis of advanced-stage ovarian Cancer mortality in California.
- Evaluation of 30-Day Hospital Readmission After Surgery for Advanced-Stage Ovarian Cancer in a Medicare Population.
- Ovarian Cancer in the United States: Contemporary patterns of care associated with improved survival.
- Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian Cancer in California.
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality.
- Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in...
- Phase 1B study of amuvatinib in combination with five standard Cancer therapies in adults with advanced solid tumors.
- Disparities in access to minimally invasive surgery for women undergoing hysterectomy in california.
- New paradigms in the surgical and adjuvant treatment of ovarian Cancer.
- Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian Cancer and the impact of race and socioeconomic status.
- The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay.
- The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian Carcinoma: A Gynecologic Oncology Group study.
- High-volume ovarian Cancer care: Survival impact and disparities in access for advanced-stage disease.
- Pathologic Features Associated with Resolution of Complex Atypical Hyperplasia and Grade 1 Endometrial AdenoCarcinoma After Progestin Therapy.
- Intraperitoneal Chemotherapy from Armstrong to HIPEC: Challenges and Promise.
- Racial disparities and patterns of ovarian Cancer surgical care in California.
- Clinical performance of a multivariate index assay for detecting early-stage ovarian Cancer.
- Impact of a Multivariate Index Assay on Referral Patterns for Surgical Management of an Adnexal Mass.
- Survival in women with grade 1 serous ovarian Carcinoma.
- Adherence to treatment guidelines for ovarian Cancer as a measure of quality care.
- Disparities in Uterine Cancer Epidemiology, Treatment, and Survival Among African Americans in the United States.
- We need a new paradigm in gynecologic Cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.
- Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status.
- Robotic surgery: gynecologic oncology.
- Impact of race and ethnicity on treatment and survival of women with vulvar Cancer in the United States.
- Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
- Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 AdenoCarcinoma: A systematic review.
- Stage I Noninvasive and Minimally Invasive Uterine Serous Carcinoma: Comprehensive Staging Associated With Improved Survival.
- CA125 Regression in Ovarian Cancer Patients Treated with Intravenous versus Intraperitoneal Platinum-Based Chemotherapy: A Gynecologic Oncology Group Study.
- "Kegel ball" induced Vaginal cuff dehiscence following radical abdominal hysterectomy: Laparoscopically-assisted transVaginal retrieval.
- Is the Easier Way Ever the Better Way?
- Recurrence patterns and surveillance for patients with early stage endometrial Cancer.
- Comparison of candidate serologic markers for type I and type II ovarian Cancer.
- Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
- Analysis of racial disparities in stage IIIC epithelial ovarian Cancer care and outcomes in a Tertiary Gynecologic Oncology Referral Center.
- Impact of payer status on treatment of Cervical cancer at a tertiary referral center.
- Racial disparities in ovarian Cancer surgical care: A population-based analysis.
- Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal Cancer surgical care.
- Volume-based trends in surgical care of patients with oropharyngeal Cancer.
- Fertility preserving options in patients with gynecologic malignancies.
- Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery...
- Volume-based trends in laryngeal Cancer surgery.
- Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal Cancer surgical care.
- Activity of sorafenib in recurrent ovarian cancer and primary peritoneal Carcinomatosis: a gynecologic oncology group trial.
- Identification of patient groups at highest risk from traditional approach to ovarian Cancer treatment.
- Volume-based trends in thyroid surgery.
- Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian Cancer.
- The National Cancer Database report on advanced-stage epithelial ovarian Cancer: impact of hospital surgical case volume on overall survival and surgical treatment par...
- Cytoreductive surgery for advanced or recurrent endometrial Cancer: a meta-analysis.
- Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian Cancer: a pilot study.
- Surveillance for the detection of recurrent ovarian Cancer: survival impact or lead-time bias?
- Predictive value of endoCervical curettage at Cervical conization and provider practices in management of high-grade Cervical dysplasia.
- Predicting the outcome of cytoreductive surgery for advanced ovarian Cancer: a review.
- Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93.
- Analysis of contemporary trends in access to high-volume ovarian Cancer surgical care.
- Impact of surgeon and hospital ovarian Cancer surgical case volume on in-hospital mortality and related short-term outcomes.
- Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian Cancer: operative technique and clinical outcome.
- Advanced cytoreductive surgery in gynecologic oncology.
- p53 autoantibodies, cytokine levels and Ovarian carcinogenesis.
- Imaging uterine Cervical cancer with FDG-PET/CT: direct comparison with PET.
- Improved progression-free and overall survival in advanced ovarian Cancer as a result of a change in surgical paradigm.
- Radical surgical cytoreduction of progressive leiomyomatosis peritonealis disseminata: a case report.
- Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
- A practical framework for patient care teams to prospectively identify and mitigate clinical hazards.
- AdenoCarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
- Cytoreductive surgery for recurrent ovarian Cancer: a meta-analysis.
- Predicting surgical outcome for advanced ovarian Cancer, surgical standards of care, and the concept of kaizen.
- Ubiquitin proteasome system stress underlies synergistic killing of ovarian Cancer cells by bortezomib and a novel HDAC6 inhibitor.
- Surgical care of young women diagnosed with ovarian Cancer: a population-based perspective.
- Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian Cancer.
- Transverse colectomy in ovarian Cancer surgical cytoreduction: operative technique and clinical outcome.
- Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
- Explained compared with unexplained fever in postoperative myomectomy and hysterectomy patients.
- Women with undiagnosed colorectal adenoCarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal aden...
- Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian Cancer.
- A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal Cancers.
- Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian Carcinoma.
- Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian Cancer: a case-control study.
- Predictors of extended intensive care unit resource utilization following surgery for ovarian Cancer.
- Concentration of uterine Cancer surgical care among the elderly: a population-based perspective.
- Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian Cancer, rapid proliferation, and motility.
- A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian Cancer using a risk-adjusted model.
- Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian Cancer: a cost-effectiveness analysis.
- Secondary cytoreduction in the management of recurrent Uterine leiomyosarcoma.
- Histologic alterations in endometrial hyperplasia and well-differentiated Carcinoma treated with progestins.
- The role of cytoreductive surgery for colon Cancer metastatic to the ovary.
- Centralization of care for patients with advanced-stage ovarian Cancer: a cost-effectiveness analysis.
- Expression of extracellular matrix proteins in Ovarian serous tumors.
- Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian Cancer.
- Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis.
- Secondary cytoreductive surgery for localized, recurrent epithelial ovarian Cancer: analysis of prognostic factors and survival outcome.
- Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results.
- Tertiary cytoreductive surgery in recurrent ovarian Cancer: selection criteria and survival outcome.
- Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian Cancer.
- Delaying the primary surgical effort for advanced ovarian Cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction.
- A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.
Schools
Keck School Of Medicine Of The Univ Of Southern California
Johns Hopkins Hospital
UCLA Med Center
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- EndoCervical Curettage
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Cervicitis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- Top Doctors:San Diego Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Super Doctor
- Fellow (FACOG)
- Fellow (FACS)
Education
-
UCLA Medical Center -
Johns Hopkins University -
Keck School of Medicine of USC
Hospital
-
Fountain Valley Regional Hospital and Medical Center -
Long Beach Memorial Medical Center -
UC Irvine Medical Center -
St. Joseph Hospital
Drug Facts
| NPI NUMBER | 1427016039 | |
| NPPES Provider LastName | BRISTOW | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 92868 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 27.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427016039 |
| Last Name Of The Provider | BRISTOW |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Epifanio P. Anzaldo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramez N. Eskander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamera Hatfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie M. Randall-Whitis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald A. Chez, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alberto Manetta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip J Disaia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishnansu S. Tewari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan L. Stephenson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ana M. Sanchez, MD
This Doctor is OpenDoctor Recommended.
|